HomeOncology
Oncology
Immune checkpoint inhibitor shrinks incurable skin cancer tumours
Clinical trials show that an immune checkpoint inhibitor shrinks the tumours of nearly half of patients with incurable, advanced cutaneous squamous-cell carcinoma, an international...
Little benefit from frequent monitoring of post-Tx prostate cancer
Prostate cancer patients who were monitored more frequently after treatment did not live significantly longer than patients who were monitored once a year, according...
No benefit from chemo for 70% of those with early breast cancer — TAILORx
Findings from the ground-breaking Trial Assigning Individualised Options for Treatment (Rx) (TAILORx) trial, show no benefit from chemotherapy for 70% of women with the...
Aspirin with acid reducers helps acid reflux patients slow cancer advance
Taking aspirin with acid reducers can help patients with chronic acid reflux slow the advance of cancer of the oesophagus, the tube from the...
Novel breast cancer Tx approach led to complete regression in patient
A novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression of breast cancer in...
Gene test could help early breast cancer patients forgo chemo
A 21-gene test performed on tumours could enable most patients with the most common type of early breast cancer to safely forgo chemotherapy, according...
Immunotherapy may halt spread of prostate cancer — UK trial
More than a third of men with an advanced form of prostate cancer were still alive and one-in-10 had not had further growth after...
Antibiotics may affect some cancer treatment outcomes
Cancer patients who took antibiotics during immunotherapy treatment lived about half as long as those who avoided the drugs, The Guardian reports a new...
Ground-breaking immunotherapy clears advanced breast cancer
A woman with advanced breast cancer which had spread around her body has been completely cleared of the disease by a ground-breaking therapy that...
Blood test may detect 10 types of cancer before tumour develops
A blood test able to detect 10 types of cancer years before a person falls ill could become available on the UK's National Health...
Non-aspirin NSAID use linked to shorter survival rates in mRCC
A University of California study has indicated that non-aspirin NSAID use was associated with shorter overall survival in patients with metastatic renal cell carcinoma...
Arterial thrombosis associated with increased incidence of cancer
Lower limb arterial thrombosis was a marker of occult cancer, especially lung cancer, and was an adverse prognostic factor for mortality in common cancers,...
Immunotherapy and chemo drug combo increases lung cancer survival rates
The immunotherapy drug pembrolizumab, when combined with chemotherapy, doubles survival in patients with non-squamous non-small cell lung cancer (NSNSCLC) lacking genetic changes in the...
Investigational drug safely and effectively treats RET-driven cancers
A phase I, first-in-human study led by The University of Texas MD Anderson Cancer Centre reveals for the first time, an investigational drug that...
Chip-based blood test for multiple myeloma may relegate bone biopsy
The diagnosis and treatment of multiple myeloma, a cancer affecting plasma cells, traditionally forces patients to suffer through a painful bone biopsy. During that...
Artificial mole as an early warning of cancer
Swiss researchers have developed and tested in mice a synthetic gene network that is implanted and serves as an early warning system against the...
One-two drug combo punch an effective treatment for lung cancers
A one-two combo punch using two currently available drugs could be an effective treatment for the majority of lung cancers, a study by scientists...
Common iron compounds may increase colon cancer risk
Two common iron compounds increase the formation of a known biomarker for cancer, according to a study of cancer cells from Chalmers University of...
High amounts of carbs may increase head and neck cancer recurrence risk
Consuming high amounts of carbohydrates and various forms of sugar during the year prior to treatment for head and neck cancer may increase patients'...
Combination Tx targets both tumour cells and tumour blood vessels
Each day, normal human cell tissues express a protein known as p53 that wages war against potential malignancies. However, between 30% and 40% of...
Higher radiation doses not improving survival in prostate cancer patients
A study shows that higher doses of radiation do not improve survival for many patients with prostate cancer, compared with the standard radiation treatment....
Promising family of silver-based anti-cancer drugs discovered
A new family of 'very promising' silver-based anti-cancer drugs has been discovered by researchers in South Africa.
The most promising silver thiocyanate phosphine complex among...
Slow-release hydrogel helps immunotherapy drug kill cancer cells
An immunotherapy drug embedded in a slow-release hydrogel invented at Rice University in collaboration with the University of Texas Health Science Centre at Houston...
High vitamin D levels may link to lower liver cancer risk
High levels of vitamin D may be linked to a lower risk of developing cancer, including liver cancer, concludes a large study of Japanese...
Active lung cancer treatment differences may be raising mortality risk
Differences in the active treatment of lung cancer across England may be cutting short the lives of hundreds of patients with the disease every...
Nuts improve colon cancer recurrence by 42%, mortality by 57%
People with stage III colon cancer who regularly eat nuts are at significantly lower risk of cancer recurrence and mortality than those who don't,...
Weighing risks and benefits in paediatric cancer trials
On average, 1 in 10 children who enrol in paediatric phase I cancer trials are improved after the trial, and 1 in 50 die...
'Obesity paradox' is a significant factor in metastatic melanoma survival
Obese patients with metastatic melanoma who are treated with targeted or immune therapies live significantly longer than those with a normal body mass index...
Kinase inhibitor could be viable in thyroid cancer therapy — trial
A kinase inhibitor called cabozantinib could be a viable therapy option for patients with metastatic, radioactive iodine-resistant thyroid cancer. In a trial initiated and...
Even disclosed placebos help cancer patients with fatigue
Long after cancer treatment ends, many continue to deal with one particular symptom that refuses to go away: fatigue. In a study, researchers at...
EU and WHO reports 'incomplete, unbalanced and uncritical' — international review
Recent reports from the European Union and the World Health Organisation that there is no safe limit for exposure to UV radiation from sunbeds,...
Higher body-fat levels link to invasive breast cancer risk
Among postmenopausal women with normal body mass index (BMI), those with higher body fat levels had an increased risk for invasive breast cancer, according...
Some cancer patients with depression have poorer survival rates
In a study of patients with head and neck cancer, even mild depressive symptoms were associated with poorer overall survival. The findings indicate that...
New cancer diagnostic blood test could 'save countless lives'
A ground-breaking new blood test that can detect eight common types of cancer before they spread will save countless lives, reports The Guardian. Scientists...
Shorter treatment may provide better outcome for some prostate cancer
Treatment with a shorter course of radiation, using higher doses per treatment over fewer days, may be the preferred approach in appropriately selected patients...
Compound may restore immune response in melanoma patients
A novel compound may restore immune response in patients with melanoma, according to a study presented at the ESMO Immuno Oncology Congress 2017. "Checkpoint...
Algerian men rejecting 'mutilated' breast cancer victims
As if losing a breast to cancer was not traumatic enough, Algerian mother-of-three Linda was then spurned by her husband for being “mutilated” and...
Cancer survivors age faster and die earlier
People who have had cancer age faster than those who haven’t lived with the disease, found researchers at the College of Medicine, Mayo Clinic...
Diabetes drug metformin inhibits MDR breast cancer
The drug metformin, typically prescribed to treat type 2 diabetes, keeps breast cancer cells from developing multiple drug resistance (MDR) and can reverse MDR...
Lobectomy best prolongs lives of early stage lung cancer patients
Patients with early stage lung cancer live longer when they receive a lobectomy – the most common type of operation for the disease –...